Imran Khan's Third Eye Procedure at PIMS
Analysis based on 31 articles · First reported Feb 23, 2026 · Last updated Feb 24, 2026
This event has minimal direct market impact as it primarily concerns the health of a political figure, Imran Khan, and the related political and judicial processes in Pakistan. It may indirectly affect investor sentiment regarding political stability in Pakistan, but no direct financial market movements are expected.
Imran Khan, the founder of Pakistan===Pakistan Tehreek-e-Insaf and former Prime Minister of Pakistan, underwent a third eye procedure at the Pakistan===Pakistan Institute of Medical Sciences (PIMS) for central retinal vein occlusion (CRVO). Doctors have declared his vision satisfactory after the administration of an anti-VEGF injection. The procedure was conducted under strict medical protocols, with Khan remaining stable throughout. This follows previous treatments in January and February. Pakistan===Pakistan Tehreek-e-Insaf has expressed concerns over the secrecy surrounding his treatment and the denial of access for his personal doctors and family, advocating for his transfer to a private hospital like Shifa International Hospital. The Pakistan===Islamabad High Court had previously directed the formation of a medical board to assess his health, rejecting the transfer request. A report on his condition was also submitted to the Pakistan===Supreme Court of Pakistan.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard